Castle Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference

Rhea-AI Summary

Castle Biosciences, Inc. (CSTL) is set to present at the 23rd Annual Needham Virtual Healthcare Conference, offering a company overview on April 9, 2024. The presentation will be available via live audio webcast on the company's website, with a replay option post-event.

FRIENDSWOOD, Texas--(BUSINESS WIRE)-- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that the Company’s executive management is scheduled to present a company overview at the 23rd Annual Needham Virtual Healthcare Conference on Tuesday, April 9, 2024, at 12:45 p.m. Eastern time.

A live audio webcast of the Company’s presentation will be available by visiting Castle Biosciences’ website at https://ir.castlebiosciences.com/events-presentations/default.aspx. A replay of the webcast will be available following the conclusion of the live broadcast.

About Castle Biosciences

Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and investors.

Castle’s current portfolio consists of tests for skin cancers, Barrett’s esophagus, mental health conditions and uveal melanoma. Additionally, the Company has active research and development programs for tests in other diseases with high clinical need, including its test in development to help guide systemic therapy selection for patients with moderate-to-severe atopic dermatitis, psoriasis and related conditions. To learn more, please visit www.CastleBiosciences.com and connect with us on LinkedIn, Facebook, X and Instagram.

DecisionDx-Melanoma, DecisionDx-CMSeq, DecisionDx-SCC, MyPath Melanoma, DiffDx-Melanoma, TissueCypher, IDgenetix, DecisionDx-UM, DecisionDx-PRAME and DecisionDx-UMSeq are trademarks of Castle Biosciences, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240402941866/en/

Investor Contact:

Camilla Zuckero

czuckero@castlebiosciences.com



Media Contact:

Allison Marshall

amarshall@castlebiosciences.com

Source: Castle Biosciences Inc.

FAQ

When is Castle Biosciences, Inc. (CSTL) presenting at the 23rd Annual Needham Virtual Healthcare Conference?

Castle Biosciences, Inc. (CSTL) is presenting at the 23rd Annual Needham Virtual Healthcare Conference on April 9, 2024.

What time is Castle Biosciences, Inc. (CSTL) scheduled to present at the conference?

Castle Biosciences, Inc. (CSTL) is scheduled to present at 12:45 p.m. Eastern time.

Where can I access the live audio webcast of Castle Biosciences, Inc. (CSTL) presentation?

The live audio webcast of Castle Biosciences, Inc. (CSTL) presentation will be available on the company's website at https://ir.castlebiosciences.com/events-presentations/default.aspx.

Will there be a replay option for Castle Biosciences, Inc. (CSTL) presentation?

Yes, a replay of the webcast will be available after the live broadcast concludes.